Home › Trial NCT06459687
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
- Trial IDNCT06459687
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorLee's Pharmaceutical Limited
- Enrollment440
- Start date2024-11-28
- ConditionsCervical Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.